Q2 2020 Regeneron Pharmaceuticals Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Regeneron Pharmaceuticals Q2 2020 Earnings Conference Call. (Operator Instructions) Please be advised, today's call is being recorded. (Operator Instructions) Thank you.
Justin Holko, I will now turn the call over to you.
Thank you, Stephanie. Good morning, good afternoon and good evening to everyone listening around the globe. Thank you for your interest in Regeneron Pharmaceuticals and welcome to the Second Quarter
2020 Conference Call. An archive of this webcast will be available on our website.
Joining me today on the call are Dr. Leonard Schleifer, Founder, President and Chief Executive Officer; Dr. George Yancopoulos, Co-Founder, President and Chief Scientific Officer; Marion McCourt, Senior Vice President and Head of
Commercial; and Bob Landry, Executive Vice President and Chief Financial Officer. After our prepared remarks, we will open the call for Q&A.
I would also like to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |